American Healthcare REIT, Inc. (AHR)
NYSE: AHR · Real-Time Price · USD
57.16
+0.57 (1.01%)
At close: Jul 17, 2026, 4:00 PM EDT
57.90
+0.74 (1.29%)
After-hours: Jul 17, 2026, 7:22 PM EDT
American Healthcare REIT Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, American Healthcare REIT stock has a consensus rating of "Strong Buy" and an average price target of $59.36. The average 1-year stock price forecast is 3.85% higher than the current stock price, while the lowest is $55 (-3.78%) and the highest is $67 (+17.21%).
Price Target: $59.36 (+3.85%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for American Healthcare REIT stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Buy | 5 | 5 | 5 | 5 | 5 | 6 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 14, 2026 |
| BMO Capital | BMO Capital | Buy Reiterates $60 | Buy | Reiterates | $60 | +4.97% | Jul 13, 2026 |
| UBS | UBS | Buy Reiterates $60 → $63 | Buy | Reiterates | $60 → $63 | +10.22% | Jul 8, 2026 |
| Barclays | Barclays | Buy Initiates $61 | Buy | Initiates | $61 | +6.72% | Jul 7, 2026 |
| Citi | Citi | Buy Upgrades $55 | Buy | Upgrades | $55 | -3.78% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
2.73B
from 2.26B
Increased by 20.85%
Revenue Next Year
3.05B
from 2.73B
Increased by 11.91%
EPS This Year
0.55
from 0.68
Decreased by -19.33%
EPS Next Year
0.86
from 0.55
Increased by 56.36%
EPS based on non-GAAP adjusted numbers.